重性抑郁障碍
神经刺激
医学
精神科
抗抑郁药
梅德林
抑郁症状
心理治疗师
重症监护医学
心理学
认知
政治学
刺激
内科学
法学
焦虑
作者
George I. Papakostas,W. Clay Jackson,Roueen Rafeyan,Madhukar H. Trivedi
标识
DOI:10.4088/jcp.ot19037br4
摘要
When a patient with major depressive disorder experiences inadequate response to an antidepressant, clinicians should employ measurement-based care strategies to improve outcomes. Evidence suggests that adjunctive therapies, such as the FDA-approved atypical antipsychotics, are efficacious when the initial treatment is well tolerated but not improving symptoms. Clinicians should consult guidelines, peer-reviewed journals, CME programs, and other sources to stay up-to-date with current and emerging treatments in this area. They should also be familiar with the available options for psychotherapy, neurostimulation, supplements, and exercise for patients who prefer alternative therapies. .
科研通智能强力驱动
Strongly Powered by AbleSci AI